ARCHIVES

EntreMed Issued U.S. Patent For Active Parts Of Endostatin.

This article is from The Cancer Letter archive.

Vol. 27 No. 09 | March 2, 2001

Download PDF Visit The Full Archive

Related Articles

Markison leaving Bristol-Myers, two others promoted in reorganization.

January 30, 2004

Pazdur: Registration Trials Run By Groups Need Same Rigor As Industry Trials

March 25, 2011

In Brief: Edward Sondik Named Director Of CDC’s National Center for Health Statistics

April 12, 1996

ASCO Picks Charles Balch To Succeed John Durant as Executive Vice President.

January 7, 2000

Early-Stage HER2+ Breast Cancer Patients Are At Significant Risk Of Recurrence

December 26, 2008

Patient Advocacy: Prostate Cancer coalition Is Formed

September 6, 1996